Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Study of ONGLYZA (Saxagliptin) Under Conditions of Actual Use

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of Type 2 Diabetes Mellitus~* Prescribed Saxagliptin by patient's attending physician~Exclusion Criteria:~* Known allergic or serious adverse reaction to Saxagliptin~* Pregnant or breastfeeding patients

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).